Títulos
Abaixo está a lista de títulos corporativos GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo | YTM % | Volume | Preço % | Cupom % | Data de vencimento | Montante em circulação | Valor de face | Valor mín. de denominação | Emissor |
|---|---|---|---|---|---|---|---|---|---|
| XXS86659697GlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | 5,72% | 0 | 82,57% | 4,250% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS29462437GlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | 5,61% | 0 | 96,09% | 5,250% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS35082093GlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | 5,44% | 0 | 108,66% | 6,375% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGX4CGlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5,18% | 0 | 88,78% | 4,200% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | 4,99% | 0 | 74,89% | 1,625% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AE7GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 4,92% | 0 | 113,52% | 6,375% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377372AQ0GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 4,61% | 0 | 101,96% | 4,875% | 2035-04-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS14051686GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | 4,55% | 0 | 104,70% | 5,250% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AB3GlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | 4,46% | 0 | 106,35% | 5,375% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS86658852GlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | 4,11% | 0 | 98,53% | 3,375% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AP2GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4,06% | 0 | 101,78% | 4,500% | 2030-04-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | 3,98% | 0 | 92,49% | 1,250% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | 3,95% | 0 | 98,08% | 3,375% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | 3,88% | 0 | 100,00% | 3,875% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AM7GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 3,79% | 0 | 100,71% | 4,315% | 2027-03-12 | 400 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | 3,48% | 0 | 97,88% | 3,250% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | 3,09% | 0 | 100,18% | 3,125% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | 2,98% | 0 | 99,42% | 2,875% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | 2,75% | 0 | 95,76% | 1,750% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | 2,61% | 0 | 95,49% | 1,375% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | 2,39% | 0 | 101,23% | 3,000% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | 2,24% | 0 | 99,44% | 1,250% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | 2,19% | 0 | 98,97% | 1,000% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 1,48 M | 100,35% | 4,727% | 2027-03-12 | 600 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0,883% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | 100.000.000,00 JPY | GlaxoSmithKline Capital Plc |